Astrana Health, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Astrana Health's 2025 annual report highlights significant revenue and Adjusted EBITDA growth driven by strategic acquisitions, despite a decline in net income and an identified material weakness in internal controls.
NASDAQ
Astrana Health's 2024 10-K filing highlights strategic acquisitions, financial performance, and future outlook in the value-based healthcare sector.
NASDAQ
Astrana Health, Inc. details its common and preferred stock structure, voting rights, dividend policies, and anti-takeover provisions in a recent SEC filing.